CDK1 and neoplasm: The downregulated CDK1 in Her2BC suggests a dysregulated cell cycle, where the bioactive compounds in OT could modulate through the disruption of the G2/M transition, leading to cell cycle arrest and thereby suppressing tumor cell proliferation [158].